Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction

Launched by MAYO CLINIC · May 29, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at how to predict gastroesophageal reflux disease (GERD) in patients who have undergone sleeve gastrectomy, a type of weight-loss surgery. Researchers want to find out what factors might lead to GERD after this procedure, which is important because GERD can cause uncomfortable symptoms like heartburn. The trial is currently recruiting participants who are adults over 18 years old, have a body mass index (BMI) of 30 or higher, and can agree to participate in the study. However, some individuals may not be eligible, especially those with certain types of esophageal problems or previous surgeries on the stomach or esophagus.

If you join this trial, you can expect to be evaluated to see if you meet the eligibility criteria. You will also be contributing to important research that could help improve the understanding of complications after sleeve gastrectomy, ultimately benefiting future patients. It's essential to know that this study is open to all genders and is focused on learning how to better predict and manage GERD in individuals who have had this type of surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients \> 18 years
• • BMI 30 or greater kg/m2
• • Participants can give a consent to the procedure
• • Participants have no contraindications to LSG (gastric ulceration)
• Exclusion Criteria:
• • Participants who have LA grade C or D esophagitis, Barrett mucosa or peptic stricture.
• • Patients who have evidence of a major motility abnormality defined by the Chicago classification version 3.0 (achalasia, absent contractility, esophagogastric junction outflow obstruction, distal esophageal spasm, or hypertensive peristalsis)
• • Patients with hiatal hernia \> 3 cm
• • Patients with previous esophageal or stomach surgery